why choose us

First received: March 01, 2023

Clinical Trial: Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Chronic Hepatitis D Infection

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-label, Parallel-group, Multiple-dose Study to Evaluate the Pharmacokinetics of Bulevirtide in Participants With Normal and Impaired Hepatic Function

Brief Summary: The goals of this study are to measure the amount of bulevirtide (BLV) that gets into the blood stream and how long it takes to get rid of it, measure the effect of BLV on bile acids, and evaluate the safety and tolerability of multiple doses of BLV in participants with normal and impaired hepatic (liver) function.

Read more